Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
28/08/2026 13:00
BRIEF-Xortx Announces Termination And Postponement Of Investor Relations Program Aug 28 (Reuters) - XORTX Therapeutics Inc XRTX.V:
XORTX ANNOUNCES TERMINATION AND POSTPONEMENT OF INVESTOR RELATIONS PROGRAM
XORTX THERAPEUTICS - EXPECTS VOLUNTARY DELISTING FROM TSXV TO TAKE EFFECT SEPTEMBER 1, 2026
Source text: ID:nGNX323j3C
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM